388 related articles for article (PubMed ID: 17552110)
21. In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin: does vancomycin resistance occur?
Kleinschmidt SL; Munckhof WJ; Nimmo GR
Int J Antimicrob Agents; 2006 Feb; 27(2):168-70. PubMed ID: 16420976
[TBL] [Abstract][Full Text] [Related]
22. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections.
Kourbatova EV; Halvosa JS; King MD; Ray SM; White N; Blumberg HM
Am J Infect Control; 2005 Sep; 33(7):385-91. PubMed ID: 16153484
[TBL] [Abstract][Full Text] [Related]
23. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
24. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Steinkraus G; White R; Friedrich L
J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus.
LaPlante KL; Rybak MJ; Amjad M; Kaatz GW
Pharmacotherapy; 2007 Jan; 27(1):3-10. PubMed ID: 17192156
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
Anastasiou DM; Morgan M; Ruane PJ; Steenbergen JN; Katz BD; Alder JD; Thorne GM
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):339-42. PubMed ID: 18304772
[TBL] [Abstract][Full Text] [Related]
27. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
Moore CL; Osaki-Kiyan P; Haque NZ; Perri MB; Donabedian S; Zervos MJ
Clin Infect Dis; 2012 Jan; 54(1):51-8. PubMed ID: 22109947
[TBL] [Abstract][Full Text] [Related]
28. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
Martínez-Aguilar G; Hammerman WA; Mason EO; Kaplan SL
Pediatr Infect Dis J; 2003 Jul; 22(7):593-8. PubMed ID: 12867833
[TBL] [Abstract][Full Text] [Related]
29. Community associated MRSA: an alert to paediatricians.
Jeyaratnam D; Reid C; Kearns A; Klein J
Arch Dis Child; 2006 Jun; 91(6):511-2. PubMed ID: 16714723
[TBL] [Abstract][Full Text] [Related]
30. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.
Hayden MK; Rezai K; Hayes RA; Lolans K; Quinn JP; Weinstein RA
J Clin Microbiol; 2005 Oct; 43(10):5285-7. PubMed ID: 16207998
[TBL] [Abstract][Full Text] [Related]
31. [Osteomyelitis associated with Staphylococcus aureus infection and reduced susceptibility to vancomycin treated with daptomycin].
Araujo F; Conde Estevez D; Encinas Barrios C
Farm Hosp; 2012; 36(5):449-51. PubMed ID: 22484104
[No Abstract] [Full Text] [Related]
32. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.
Jongsma K; Joson J; Heidari A
J Antimicrob Chemother; 2013 Jun; 68(6):1444-5. PubMed ID: 23341127
[No Abstract] [Full Text] [Related]
33. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Micek ST
Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
[TBL] [Abstract][Full Text] [Related]
34. Community-acquired methicillin-resistant Staphylococcus aureus infections in children.
Kaplan SL
Semin Pediatr Infect Dis; 2006 Jul; 17(3):113-9. PubMed ID: 16934705
[TBL] [Abstract][Full Text] [Related]
35. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
Golden M; Shaib W; Havill N
Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108
[No Abstract] [Full Text] [Related]
36. Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies.
Keel RA; Sutherland CA; Aslanzadeh J; Nicolau DP; Kuti JL
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):326-9. PubMed ID: 20955917
[TBL] [Abstract][Full Text] [Related]
37. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
[TBL] [Abstract][Full Text] [Related]
38. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.
Nichol KA; Adam HJ; Hussain Z; Mulvey MR; McCracken M; Mataseje LF; Thompson K; Kost S; Lagacé-Wiens PR; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):320-5. PubMed ID: 21353960
[TBL] [Abstract][Full Text] [Related]
39. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections.
McCaskill ML; Mason EO; Kaplan SL; Hammerman W; Lamberth LB; Hultén KG
Pediatr Infect Dis J; 2007 Dec; 26(12):1122-7. PubMed ID: 18043449
[TBL] [Abstract][Full Text] [Related]
40. [In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].
Celikbilek N; Ozdem B; Gürelik FC; Güvenman S; Güner HR; Açıkgöz ZC
Mikrobiyol Bul; 2011 Jul; 45(3):512-8. PubMed ID: 21935784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
